Beck Mack & Oliver LLC Bristol Myers Squibb CO Transaction History

Beck Mack & Oliver LLC

$4.44 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$48.48 - $57.85 $7,756 - $9,256	-160 Reduced 2.3%	6,797 $348,000
Q2 2023 Aug 08, 2023	SELL	$63.71 - $70.74 $24,846 - $27,588	-390 Reduced 5.31%	6,957 $444,000
Q1 2023 May 15, 2023	SELL	$65.71 - $74.53 $657 - $745	-10 Reduced 0.14%	7,347 $509,000
Q3 2022 Nov 10, 2022	SELL	$0.13 - $76.84 $24 - $14,292	-186 Reduced 2.47%	7,357 $523,000
Q2 2022 Aug 12, 2022	SELL	$72.62 - $79.98 $250,829 - $276,250	-3,454 Reduced 31.41%	7,543 $581,000
Q1 2022 May 16, 2022	SELL	$61.48 - $73.72 $157,265 - $188,575	-2,558 Reduced 18.87%	10,997 $803,000
Q4 2021 Jan 28, 2022	SELL	$53.63 - $62.52 $40,222 - $46,890	-750 Reduced 5.24%	13,555 $845,000
Q3 2021 Nov 04, 2021	SELL	$59.17 - $69.31 $14,851 - $17,396	-251 Reduced 1.72%	14,305 $846,000
Q2 2021 Jul 28, 2021	BUY	$61.91 - $67.42 $281,628 - $306,693	4,549 Added 45.46%	14,556 $973,000
Q1 2021 May 11, 2021	SELL	$59.34 - $66.74 $296,403 - $333,366	-4,995 Reduced 33.3%	10,007 $632,000
Q4 2020 Feb 10, 2021	SELL	$57.74 - $65.43 $106,010 - $120,129	-1,836 Reduced 10.9%	15,002 $931,000
Q3 2020 Nov 02, 2020	SELL	$57.43 - $63.64 $59,727 - $66,185	-1,040 Reduced 5.82%	16,838 $1.02 Million
Q2 2020 Aug 10, 2020	SELL	$54.82 - $64.09 $285,064 - $333,268	-5,200 Reduced 22.53%	17,878 $1.05 Million
Q1 2020 May 05, 2020	SELL	$46.4 - $67.43 $18,560 - $26,972	-400 Reduced 1.7%	23,078 $1.29 Million
Q4 2019 Feb 07, 2020	BUY	$49.21 - $64.19 $292,159 - $381,096	5,937 Added 33.85%	23,478 $1.51 Million
Q3 2019 Nov 06, 2019	SELL	$42.77 - $50.71 $48,458 - $57,454	-1,133 Reduced 6.07%	17,541 $890,000
Q2 2019 Aug 13, 2019	SELL	$44.62 - $49.34 $98,074 - $108,449	-2,198 Reduced 10.53%	18,674 $847,000
Q1 2019 May 02, 2019	SELL	$45.12 - $53.8 $90,240 - $107,600	-2,000 Reduced 8.74%	20,872 $996,000
Q4 2018 Feb 04, 2019	SELL	$48.76 - $63.23 $14,628 - $18,969	-300 Reduced 1.29%	22,872 $1.19 Million
Q3 2018 Oct 29, 2018	SELL	$55.19 - $62.25 $20,696 - $23,343	-375 Reduced 1.59%	23,172 $1.44 Million
Q2 2018 Jul 25, 2018	SELL	$50.53 - $62.98 $30,368 - $37,850	-601 Reduced 2.49%	23,547 $0
Q1 2018 Apr 25, 2018	SELL	$59.92 - $68.98 $59,920 - $68,980	-1,000 Reduced 3.98%	24,148 $0
Q3 2017 Oct 27, 2017	BUY	$55.23 - $63.74 $1.39 Million - $1.6 Million	25,148	25,148 $0

Others Institutions Holding BMY

# of Institutions

2,533

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

Vanguard Group Inc Valley Forge, PA

189M
Shares

$11.1 Billion
0.18% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$9.34 Billion
0.15% of portfolio
State Street Corp Boston, MA

92.9M
Shares

$5.47 Billion
0.2% of portfolio
Jpmorgan Chase & CO New York, NY

77.9M
Shares

$4.59 Billion
0.33% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

61M
Shares

$3.59 Billion
0.61% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Beck Mack & Oliver LLC, based on Form 13F filings with the SEC.

News

Stay updated on Beck Mack & Oliver LLC with notifications on news.

Account